Luminal breast tumors, expressing both ER and PR, were obtained from women who had taken E HRT or E+MPA HRT, and were used to examine PRA and PRB regulation, nuclear p27, RANKL, and the proliferation marker Ki67. Here, ESR1 is linked to breast neoplasm.